NEWSROOM

Medical Devices

UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel

    Tampa, FL, August 02, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) ("UAT Group") announced today that its subsidiary, The Dreaming Company, is expanding on its Hygieia product line with the launch of a new premium revitalizing eye gel. The Dreaming Company CEO, Blake Cooley, stated: “We engineered our Hygieia Eye Gel to redefine the standard in under eye care for puffy under eyes. This addition to the Hygieia Skin Care line will help women...

read more

UAT Group Subsidiary, Ossifix Orthopedics Announces First Scheduled Surgeries with Proprietary Bone Pin

  Tampa, FL, July 28, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) ("UAT Group"), announce today that its subsidiary, Ossifix Orthopedics has agreed to be the exclusive supplier of allograft bone pins to several surgical centers in San Antonio and Houston Texas. In just a couple of weeks, the industry first Javelin bone pin will see its first implantation in mid-august of this year. Constructed of select, high-density, allograft, cortical bone, the...

read more

RemSleep Holdings Inc. Commences Trading on OTCQB

    Tampa, FL, July 27, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, is pleased to announce that the company’s common shares will begin trading on the OTCQB Market as of the opening of the market on today, July 27, 2022. The OTCQB is the premiere marketplace for entrepreneurial and development stage U.S. and international companies that...

read more

UAT Group Subsidiary, The Dreaming Company Announces Hygieia Bedding Line

  Tampa, FL, July 26, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) ("UAT Group") announced today that its subsidiary, The Dreaming Company, is expanding on the Hygieia product line with the launch of a new premium bedding line, Hygieia Sleep. The Dreaming Company CEO, Blake Cooley, stated: “We have spent a lot of time and energy helping Americans to expose their inner goddess with our Hygieia Skin brand. Hygieia Sleep is an extension of that. Great skin...

read more

RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company Self Service Press Release

  Tampa, FL, July 22, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, announces the company has formally retained a new Senior Director for Regulatory Compliance and Regulatory submissions to gain FDA clearance to market the company’s medical device respiratory products. In addition, a new Regulatory Testing Company has been engaged.  Both will...

read more

RemSleep Holdings Inc. Issues Correction to July 12th, 2022 Press Release

  Tampa, FL, July 19, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, provides today, an update to the Company’s press release entitled, “RemSleep Holdings Inc. Announces Acceptance and Approval of the Company’s OTCQB Application” which was issued on July 12th, 2022. In said press release, RemSleep stated, “…announced today that the company has...

read more

UAT Group Subsidiary, Ossifix Orthopedics, Launching Demineralized Bone Matrix Product

  Tampa, FL, July 19, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) ("UAT Group") announced today that its subsidiary Ossifix Orthopedics has added a new product to its expanding suite of orthopedic products. Launching in August, the company projects this new product to add to its bottom line with year over increases to exceed as much as 20%. The demineralized bone matrix market is projected to reach $838.9 million USD by 2028, with 4.3% CAGR....

read more

RemSleep Holdings Inc. Announces Acceptance and Approval of the Company’s OTCQB Application

  Tampa, FL, July 12, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients, announced today that the company has officially received approval to be uplisted to OTCQB® status with otcmarkets.com. We anticipate OTCQB® status to be live on otcmarkets.com within 24-48 hours of this press release. The move to the OTCQB® exchange provides enhanced investor...

read more

RemSleep Holdings Inc Addresses Shareholders

  Tampa, FL, June 16, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, would like to address shareholders regarding the S-1 filing from June 15th, 2022. First and foremost, we want to be clear, we did not file the S-1 out of necessity. This was set up as a precautionary safety net given the current global and U.S. economic dynamics, and the...

read more

RemSleep Holdings Inc. Submits Application For Uplisting to OTCQB

  Tampa, FL, June 10, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today announced that the company has officially filed its application for OTCQB® status with otcmarkets.com. The company anticipates receiving a decision on the application in approximately 3-4 weeks. The Company believes that the move to the OTCQB® will provide enhanced...

read more

RemSleep Holdings Inc. Issues a Letter from the CEO

  Tampa, FL, June 06, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today provides a corporate update and letter from CEO Tom Wood. Dear Shareholders, On Friday the 27th of May, we were informed by the FDA after months of waiting, the DeltaWave will be reclassified under 510K review as an implantable device. Consequently, additional testing is...

read more

RemSleep Holdings Inc. Announces 510(k) Submission for DeltaWave

  Tampa, FL, May 6, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today announced that the company has responded to the Additional Information request pertaining to their current 510(k) application to the U.S. Food and Drug Administration (FDA) for its patented DeltaWave device, a nasal mask CPAP interface. https://youtu.be/6Dtl4485Yn8 “This...

read more

RemSleep Holdings Inc. Provides a Shareholder Update

  Tampa, FL, March 28, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, provides a corporate update to the company’s shareholders. When submitting a 510k for a device such as the DeltaWave, there are a myriad of tests that need to be carried out to prove to the FDA that the device is safe and effective. The company has diligently carried out...

read more

RemSleep Holdings Announces Significant Distribution Agreement for Nasal CPAP Machines to Address USA CPAP Shortage

  Tampa, FL, March 22, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is excited to announce that the company has recently negotiated an agreement with an overseas manufacturer for the import of nasal CPAP machines. The initial order of 1500 units has been placed and the shipment of nasal CPAP devices will be expected to occur in mid-April,...

read more

UAT Group Subsidiary, Ossifix Orthopedics, Javelin Fixation Pin Enters Ortho Market

  Tampa, FL, March 10, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (UAT Group), announced today that its subsidiary, Ossifix Orthopedics has entered into full scale production of its Javelin fixation pin. Ossifix CEO, Mark Estrada, stated: “The initial manufacturing of the first 200 units allowed us to dial in tolerances and streamline the manufacturing process. From here on out we anticipate manufacturing an average of 2000 units monthly with 12%-20%...

read more

Michael O’Shea CEO, Releases Shareholder Update

  Mauldin, SC, March 09, 2022 -- McapMediaWire -- Xcelerate, Inc. (OTC Pink: XCRT) Michael O’Shea, CEO, today released a shareholder update. “As recently announced, Xcelerate has acquired a 51% membership interest in AfiyaSasa Africa, LLC (“ASA”) (Swahili “Health Now Africa”). We are now excited to announce that Dr. Dilan Elegalla has relocated to Tanzania to establish a pilot program and ASA has hired four employees including C.E.O. Sriyanjit Perera. Sriyanjit served for 10 years in Dar...

read more

TIPS Announces Appointment of Bolko & Associates, LLC as Independent Auditor, as Company Prepares for Full SEC Reporting Status and OTCQB Up-list

London, England, March 01, 2022, McapMediaWire -- Tianrong Internet Products and Services, Inc. (OTC Pink: TIPS), a MedTech and Medical Device Company, today announced that the Company has engaged Bolko & Associates, LLC (“Bolko”) as its independent auditor, as TIPS prepares to become a fully reporting company with the SEC. The Company anticipates filing the appropriate registration statement with the SEC within the coming weeks. In addition, TIPS, upon completion of the audit, will file...

read more

Fran White to Join the Advisory Board of Xcelerate, Inc.

  Mauldin, SC , Feb. 15, 2022 -- McapMediaWire -- Xcelerate, Inc. (OTC Pink: XCRT) today announced that Fran White has accepted an invitation to join its Advisory Board effective immediately. Fran founded MDC Associates more than 30 years ago. MDC is a consulting company specializing in regulatory affairs management in the medical device and biotechnology industries. Their clients include many of the leading companies in the biotech and diagnostic industries. Prior to founding MDC, Fran...

read more

UAT Group Subsidiary, Ossifix Orthopedics, Begins Production of Fixation Pin, Significant Sales Expected

  Tampa, FL, Feb. 14, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (UAT Group), announced today that it has begun fulfilling purchase orders and contracts for orthopedic distributors and clients nationwide. Ossifix engineers and manufactures 100% allograft bone implants for small bone, extremities, and sports medicine markets that also has applications in the craniofacial, spine and oral surgery procedures. Resorbable implant technology is readily...

read more

NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION

    IRVINE, CA, Feb. 11, 2022 -- McapMediaWire -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. (OTC Pink: ODYY) today announced the continued enrollment of its first in kind human clinical trial of its proprietary drug compound intended to treat concussion. NFL Hall of Fame Quarterback Brett Favre is one of the high-profile personalities having made headlines for his push to improve concussion treatments and protocols in the NFL, as well as other contact sports around...

read more

RemSleep Holdings Inc Announces Engagement of New Investor Relations Firm and News Distributor

  Tampa, FL, Jan. 24, 2022 -- McapMediaWire -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because...

read more

UAT Group Announces Transfer Agent Change

  Tampa, FL, Jan. 12, 2022 -- McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) (UAT Group), announced today that it has replaced Equiniti Group PLC as the registrar and transfer agent of the Company's common shares with ClearTrust, LLC. Shareholders do not need to take any action with respect to the change in transfer agent and registrar services. All inquiries and correspondence relating to the shareholder records, transfer of shares, lost certificates, and or...

read more

TIPS ANNOUNCES ACQUISITION TARGET, CAMBRIDGE ORTHOPAEDIC LABS

  London, England , Dec. 10, 2021 -- McapMediaWire -- Tianrong Internet Products and Services, Inc. (OTC Pink: TIPS), a MedTech and Medical Device Investment Company, today announced that it has selected Cambridge Orthopaedic Labs Ltd (“COL”) (https://www.wiltongroup.com/col/) as its next equity acquisition candidate. COL is a medical device company that has developed an innovative non-invasive external fixator (PolyArmour) for the treatment of broken bones, focusing initially on wrist...

read more

TIPS ANNOUNCES TAKEOVER BY WILTON MANAGEMENT LIMITED, TO ENTER $8 TRILLION GLOBAL HEALTHCARE MARKET

  London, England, Dec. 03, 2021 -- McapMediaWire -- Tianrong Internet Products and Services, Inc. (OTC Pink: TIPS), a MedTech and Medical Device Investment Company, today announced that it has been acquired by Wilton Management Limited, a wholly-owned subsidiary of the London based, Wilton https://www.wiltongroup.com/. By virtue of this acquisition, Wilton now holds 59% of TIPS common stock. Wilton is a diverse financial services company, whose locations include London, Dublin and Dubai....

read more

UAT Group Strategic Partner NextCast Receives Patent Approval

  Tampa, FL, Oct. 18, 2021 -- McapMediaWire -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (“UAT Group”) announced today that strategic partner Next Casting Technologies has received its Notice of Allowance from the United States Patent Office, paving the way for its advanced SmartCast, IntelliBrace and BioSplint technology to enter into patented production. UAT Chief Executive Officer Alex Umbra, stated, “The NextCast SmartCast system has been under development and testing for...

read more

UAT Group Inc. Acquires Additional 6% of Next Casting Technologies

  Tampa, FL, Aug. 26, 2021 -- McapMediaWire -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) announced today that it has purchased an additional 6% of the Austin, Texas-based medical company Next Casting Technologies. Chief Executive Officer, Alex Umbra commented: "Increasing our equity position to 26% will further expand our value position and ROI. Continuing to expand on this partnership is in keeping with our growth through acquisition strategy and is a core principle of our...

read more

Electromedical Technologies and Nazarbayev University to Commence Landmark Alzheimer’s Disease Research Program

  The Stage I research program now includes development of targeted Alzheimer's Disease therapy using bioelectronics Experienced neuroscientist Dr. Sholpan Askarova to lead neuromodulation research program Key objective is identification of electrical frequencies with a neuroprotection potency Novel approach could emerge as alternative Alzheimer's Disease therapy to current, ineffective pharmaceuticals Global therapy market is huge, estimated to reach $13.3 billion in 2023  ...

read more

UAT Group Affiliate, Bacter Scientific to File 510(k) While Awaiting EUA Approval

  Austin, TX, July 13, 2021 – McapMediaWire -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) Affiliate and strategic partner, Bacter Scientific, Inc., a privately held, molecular diagnostics and infection detection medical research company, announced today that the Office of In Vitro Diagnostics and Radiological Health and Office of Product Evaluation and Quality within the U.S. Food and Drug Administration (FDA) accepted the company’s request for a Pre-Emergency Use...

read more

UAT Group Inc. Buys 10% Stake in Bacter Scientific, Inc.

  Tampa, FL, March 19, 2021 - - Umbra Applied Technologies Group, Inc (OTC Pink: UATG) announced today that it has purchased 10% of the Austin, Texas based medical company Bacter Scientfic, Inc. Bacter Scientific is a medical device manufacturer specializing in the development of products that detect and prevent infection in clinical, commercial, industrial and residential environments. The rising number of incidences of healthcare-acquired infections (HAIs) following hospital admittance...

read more

UAT Group, Inc. Completes Bid to Acquire Orthopedic Implant Company

  Tampa FL, March 16, 2021 – -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (UAT Group), announced today that it has initiated the acquisition of the Texas based company Ossifix Technologies, Inc. The Ossifix Orthopedics™ line of products will compete in one of the fastest growing, emerging markets, specifically, the resorbable implant market, in three distinct surgical segments; orthopedic, dental, and general.  Ossifix products are designed to be used in hospitals, ambulatory...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »